192,329 Corteva, Inc. $CTVA Shares Bought by Douglas Lane & Associates LLC

Douglas Lane & Associates LLC boosted its position in shares of Corteva, Inc. (NYSE:CTVA) by 3,476.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 197,862 shares of the company’s stock after purchasing an additional 192,329 shares during the quarter. Douglas Lane & Associates LLC’s holdings in Corteva were worth $15,364,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CTVA. Wellington Management Group LLP grew its position in shares of Corteva by 941.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after purchasing an additional 6,881,875 shares in the last quarter. Rakuten Investment Management Inc. bought a new position in Corteva during the 2nd quarter worth $9,132,000. Kingsview Wealth Management LLC acquired a new position in Corteva in the 2nd quarter valued at $1,093,000. Jupiter Topco LLC bought a new stake in shares of Corteva during the 2nd quarter valued at $544,246,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Corteva in the second quarter worth $392,447,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. New Street Research set a $17.00 price objective on shares of Corteva in a research note on Monday. The Goldman Sachs Group reissued a “buy” rating and set a $20.00 target price on shares of Corteva in a research note on Thursday. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $17.00 price target on shares of Corteva in a report on Wednesday. Argus reaffirmed a “buy” rating and set a $91.00 target price on shares of Corteva in a research note on Friday, September 18th. Finally, JPMorgan Chase & Co. raised Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price objective on the stock in a report on Tuesday. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $64.00.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: KeyBanc upgraded Corteva after the Vylor spinoff, arguing that the streamlined crop-protection business could generate “meaningful” earnings growth after 2027. The firm maintained an Overweight rating and a $17 price target, above the stock’s recent trading level. Corteva Could See Meaningful Earnings Growth After 2027
• Positive Sentiment: A Seeking Alpha analysis maintained a bullish view, citing Corteva’s constructive long-term growth and margin outlook. The completed separation may allow management and investors to value the remaining business more clearly. Corteva: A Buy On Constructive Growth And Margin Outlook
• Positive Sentiment: Unusually heavy call-option activity indicates that some traders are positioning for a potential rebound or upside move, although options activity alone does not establish a fundamental improvement. Investors Buy Large Volume of Corteva Call Options
• Neutral Sentiment: KeyCorp’s longer-term estimates project EPS of $1.15 in fiscal 2027, $1.30 in 2028 and $1.60 in 2029, while retaining an Overweight rating and $17 target. The estimates provide a positive valuation framework but are below the $1.69 consensus forecast for the current year. KeyCorp Corteva Estimates
• Negative Sentiment: Zacks Research downgraded Corteva from Hold to Strong Sell, adding pressure to the shares and highlighting continued skepticism about the post-spinoff crop-protection business. Corteva Downgraded by Zacks Research
• Negative Sentiment: Commentary from Jim Cramer was more favorable toward the newly separated Vylor seed business than Corteva’s remaining operations, suggesting that investors may view the crop-protection segment as the less attractive part of the breakup. Jim Cramer on Corteva’s Breakup

Corteva Stock Down 3.8%

Corteva stock traded down $0.52 during mid-day trading on Friday, reaching $13.23. The stock had a trading volume of 14,596,479 shares, compared to its average volume of 6,535,720. The firm has a market capitalization of $8.83 billion, a PE ratio of 8.74, a price-to-earnings-growth ratio of 1.25 and a beta of 0.57. Corteva, Inc. has a fifty-two week low of $11.74 and a fifty-two week high of $90.97. The stock’s 50-day simple moving average is $72.79 and its 200-day simple moving average is $78.74. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period last year, the business earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 1.69 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

Corteva Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.